Comparative policy analysis reveals diverse legal frameworks for stem cell–based embryo models across Asian jurisdictions, highlighting the need for global regulatory consensus.
This paper examines legal frameworks and ongoing debates concerning research with human stem cell–based embryo models (SCBEMs) in China, Japan, Malaysia, Singapore, South Korea, and Taiwan. Given their great potential for research and their ethical implications, insights from these legislations could help to clarify and formulate global consensus on the regulation of SCBEM research.
No takes yet. Share an insight, caveat, or question.
Sawai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: